63 related articles for article (PubMed ID: 7703525)
1. Effect of 6(5H)-phenanthridinone, an inhibitor of poly(ADP-ribose) polymerase, on cultured tumor cells.
Weltin D; Marchal J; Dufour P; Potworowski E; Oth D; Bischoff P
Oncol Res; 1994; 6(9):399-403. PubMed ID: 7703525
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the antiproliferative activity of anticancer drugs in hematopoietic tumor cell lines by the poly(ADP-ribose) polymerase inhibitor 6(5H)-phenanthridinone.
Holl V; Coelho D; Weltin D; Hyun JW; Dufour P; Bischoff P
Anticancer Res; 2000; 20(5A):3233-41. PubMed ID: 11062748
[TBL] [Abstract][Full Text] [Related]
3. Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP).
Griffin RJ; Srinivasan S; Bowman K; Calvert AH; Curtin NJ; Newell DR; Pemberton LC; Golding BT
J Med Chem; 1998 Dec; 41(26):5247-56. PubMed ID: 9857092
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of PARP activity by PJ-34 leads to growth impairment and cell death associated with aberrant mitotic pattern and nucleolar actin accumulation in M14 melanoma cell line.
Chevanne M; Zampieri M; Caldini R; Rizzo A; Ciccarone F; Catizone A; D'Angelo C; Guastafierro T; Biroccio A; Reale A; Zupi G; Caiafa P
J Cell Physiol; 2010 Feb; 222(2):401-10. PubMed ID: 19890834
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic and genotoxic effects of a methyl sulfonate ester that selectively generates N3-methyladenine and poly(ADP-ribose) polymerase inhibitors in normal peripheral blood lymphocytes.
Tentori L; Portarena I; Vernole P; Gold B; Graziani G
Cancer Chemother Pharmacol; 2002 Mar; 49(3):217-24. PubMed ID: 11935214
[TBL] [Abstract][Full Text] [Related]
7. Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia.
Chiarugi A; Meli E; Calvani M; Picca R; Baronti R; Camaioni E; Costantino G; Marinozzi M; Pellegrini-Giampietro DE; Pellicciari R; Moroni F
J Pharmacol Exp Ther; 2003 Jun; 305(3):943-9. PubMed ID: 12606624
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update.
Horvath EM; Szabó C
Drug News Perspect; 2007 Apr; 20(3):171-81. PubMed ID: 17520094
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of novel, potent and orally bioavailable benzimidazole inhibitors of poly(ADP-ribose) polymerase (PARP) with a quaternary methylene-amino substituent.
Zhu GD; Gandhi VB; Gong J; Thomas S; Luo Y; Liu X; Shi Y; Klinghofer V; Johnson EF; Frost D; Donawho C; Jarvis K; Bouska J; Marsh KC; Rosenberg SH; Giranda VL; Penning TD
Bioorg Med Chem Lett; 2008 Jul; 18(14):3955-8. PubMed ID: 18586490
[TBL] [Abstract][Full Text] [Related]
12. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
Wesierska-Gadek J; Schmid G
Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
[TBL] [Abstract][Full Text] [Related]
14. Screening of potential chemopreventive agents using biochemical markers of carcinogenesis.
Sharma S; Stutzman JD; Kelloff GJ; Steele VE
Cancer Res; 1994 Nov; 54(22):5848-55. PubMed ID: 7954413
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia.
Moroni F; Meli E; Peruginelli F; Chiarugi A; Cozzi A; Picca R; Romagnoli P; Pellicciari R; Pellegrini-Giampietro DE
Cell Death Differ; 2001 Sep; 8(9):921-32. PubMed ID: 11526447
[TBL] [Abstract][Full Text] [Related]
16. Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout cells to antitumor triazoloacridone C-1305 is associated with permanent G2 cell cycle arrest.
Wesierska-Gadek J; Schloffer D; Gueorguieva M; Uhl M; Skladanowski A
Cancer Res; 2004 Jul; 64(13):4487-97. PubMed ID: 15231658
[TBL] [Abstract][Full Text] [Related]
17. [Researched of PJ34 which is protective effect on the glutamate-induced HT-22 cell damage].
Fan HB; Wang YN; Geng DQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):712-3. PubMed ID: 20862804
[TBL] [Abstract][Full Text] [Related]
18. The role of poly(ADP-ribose) polymerase (PARP) in the autonomous proliferative response of endothelial cells to hypoxia.
Abdallah Y; Gligorievski D; Kasseckert SA; Dieterich L; Schäfer M; Kuhlmann CR; Noll T; Sauer H; Piper HM; Schäfer C
Cardiovasc Res; 2007 Feb; 73(3):568-74. PubMed ID: 17196568
[TBL] [Abstract][Full Text] [Related]
19. GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase.
Zhang J; Lautar S; Huang S; Ramsey C; Cheung A; Li JH
Biochem Biophys Res Commun; 2000 Nov; 278(3):590-8. PubMed ID: 11095954
[TBL] [Abstract][Full Text] [Related]
20. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]